TDF litigation is in early stages.
Thursday, March 5, 2020 – Litigation continues to move forward for plaintiffs who have suffered kidney, bone, and/or teeth issues after using Truvada and other drugs with the active ingredient tenofovir disoproxil fumarate (TDF). The OnderLaw Truvada litigation team has been working to obtain and review pharmacy and medical records to ensure each case is viable for trial. This process is long and tedious, but will be critical for a positive outcome for all of the plaintiffs involved.
The team has already contacted everyone to-date for whom records or other information was needed. If we need additional documentation from you, you will be notified directly.
As we’ve shared in the past, multidistrict litigations (MDLs), like these cases, take time. We understand the frustrations. After all, we too are at the mercy of court dockets, conflicting schedules, continuances, and other delays. Rest assured, however, that our team is always working behind the scenes to bring you justice.
Thank you for your patience as we continue our work. We are dedicated to holding companies accountable for putting profits over people. No one is arguing that HIV prevention is bad, but we intend to prove in court that Gilead and other manufacturers knew there were safer alternatives to TDF, but that they continued to cause undue risk for their own financial gains.
It’s not too late to file claims against Gilead and other TDF drug providers. Anyone who has suffered kidney, bone, or teeth issues after taking Truvada can still submit a claim. Time is of the essence. Contact us today for a free, no-obligation consultation. We don’t get paid unless you win your case.
